Tests a tube feeding formula for weight loss in obese people fed by tube
Tests a low-calorie, high-protein tube feeding formula in adults with obesity.
Key facts
- Who runs it
- Mayo Clinic
- Where
- Rochester, United StatesSee the site
- Trial code
- Registry title
- Evaluating Benefit of Peptide Based Diet in Obese HEN Patients
- Status
- Enrolling by invitation
- People taking part
- 12 people, planned
- Started
- 25 Mar 2023
- Expected to end
- Dec 2027
- Type of study
- Interventional
- Treatments tested
- Peptamen Intense VHP, Nestlé Health Science, Switzerland
- Record updated
- 26 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with obesity who get most of their nutrition through a feeding tube at home and have had a stroke.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- BMI over 30, history of stroke, on home tube feeding that gives at least 90% of energy needs.
- Earlier treatment
- Weight must have been stable over the past month.
Main reasons for not taking part
- Cancer with active treatment (chemotherapy, radiation, immunotherapy)
- Life expectancy of less than 6 months
- Stage IV or higher kidney disease (GFR < 30)
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Home Enteral Nutrition (HEN) patient receiving at least 90% of energy needs from enteral nutrition
- BMI > 30
- History of stroke
- Weight stable over the past month
Who cannot take part
- Diagnosis of cancer undergoing active treatment (chemotherapy, radiation, immunotherapy)
- Stage IV or higher kidney disease (GFR < 30)
- Life expectancy of less than 6 months
Where in United States
- Mayo Clinic in RochesterRochester, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The purpose of this study is to assess the effects of a low energy, high protein tube feeding formula on body weight in tube fed patients who are obese. It will also assess study formula tolerance as well as impact of the study formula on lean body mass, blood pressure, blood sugar and lipids.
The group in the trial
- Peptamen Intense in obese home enteral nutrition patients after strokeTreatment being tested
Subjects currently enrolled in Mayo Clinic Home Enteral Nutrition (HEN) program and anticipated to require tube feedings to provide 90% or more of feeding needs will be placed on a Peptamen Intense VHP for up to 12 weeks.
Treatment: Peptamen Intense VHP, Nestlé Health Science, Switzerland
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effect of Hypocaloric, High-protein Enteral Formula on Body Weight and Health Outcomes in Obese HEN Patients: A Pilot Study
- Plain-language title
- Tests a tube feeding formula for weight loss in obese people fed by tubeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 26 January 2026